the aid library

Профилактика инфекций и инфекционный контроль в медицинских учреждениях, обеспечивающих реагирование на COVID-19: модуль из комплекса инструментов для оценки способности служб здравоохранения к реагир
recommended

World Health Organization WHO (2020) C_WHO

A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim Guidance 20 October 2020. This self-assessment tool is designed for acute health-care facilities (i.e. tertiary and secondary) but can be modified for the use in long-term care facilities ... more

Положение дел в области санитарно-эпидемиологического надзора за состоянием окружающей среды на предмет выявления вируса SARS-CoV-2

Всемирная Организация Здравоохранения ВОЗ (2020) C_WHO

Эпиднадзор за состоянием окружающей среды посредством исследования сточных вод на наличие патогенных микроорганизмов давно применяется в общественном здравоох� ... more

Ключевые сообщения и действия по предотвращению и контролю COVID-19 в школах

unicef UNICEF (2020) C1

Цель настоящего документа заключается в предоставлении конкретных и осуществимых указаний по выполнению мер для предотвращения, ранн ... more

Surgical site infection prevention recommendations: Intraoperative Period

World Health Organization WHO (2018) C_WHO

Infographic

HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma - A Tale of Two Proteins: Tax and HBZ

Chou-Zen Giam; Semmes, Oliver John (2016) CC3

published in: Viruses 2016, 8, 161

WHO/UNICEF Strategic Plan for Polio Outbreak Response in the Middle East

The Polio Global Eradication Initiative WHO (2013)

THE SYRIAN ARAB REPUBLIC, IRAQ, JORDAN, LEBANON, TURKEY, WEST BANK AND GAZA STRIP, EGYPT

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

World Health Organization WHO (2018) C_WHO

These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. The 2018 edition of the guidelines includes the re ... more

Mesures de Base contre les infections associées aux soins

Organisation Mondiale de la Santé OMS (2007)

Core components of infection prevention and control programmes in health care

World Health Organization (2011)

Guidance on chlamydia control in Europe

European Centre for Disease Prevention and Control (2016) C1

This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes. The aim of this guidance is to suppo ... more

Poorly Designed PPE a Global Problem forWomen HealthWorkers

Kuehn, B.M. (2022) C1

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

1.0 PURPOSE To define the procedure for the conduct of in-person meetings in both healthcare and community settings in response to COVID-19 and with respect to Public Health and Social Measures (PHSMs) to reduce the risk of disease transmission. A general risk assessment must be conducted to inform ... more

Overview of technologies for the treatment of infectious and sharp waste from health care facilities

World Health Organization WHO (2020) C_WHO

This document provides an overview of specific health care waste technologies for the treatment of solid infectious and sharp waste. For each technology, details of its operation, effects on the environment and health, requirements for installation, capacities for treating waste, examples of consuma ... more

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Une meilleure gestion des déchets d’activités de soins

Rushbrook, R.; Zghondi, R. OMS; Banque Mondiale (2005) C_WHO

Une composante intégrale de l’investissement dans la santé

WHO aircraft disinsection methods and procedures

World Health Organization WHO (2023) C_WHO

2nd edition. This document describes the latest methods and procedures for disinsection of internal areas of passenger, military and cargo aircraft to prevent international transport of mosquito vectors of human diseases and protect aircraft passengers and airline crew. It provides updates on insect ... more

Apto para mujeres? Mejora del equipo de protección personal (EPP) para las mujeres trabajadoras de la salud y el cuidado

Women for Global Health WGH (2022) CC

Una de las muchas desigualdades de género en el personal sanitario y asistencial que COVID-19 ha puesto de manifiesto es la relativa al ajuste y el diseño de los equipos de protección individual (EPP). La rápida aparición y la escala de COVID-19 condujeron a la escasez de EPP en la mayoría de ... more

Progress on WASH in health care facilities 2000-2021: Special focus on WASH and infection prevention and control (IPC)
recommended

World Health Organization WHO; UNICEF, JMP (2022) C_WHO

Achieving universal access to WASH in health care facilities requires political will and strong leadership at both national and facility levels, but is highly cost-effective, and would yield substantial health benefits. A global analysis estimated that universal basic WASH services in health care f ... more